Trinity Biotech (TRIB) Raw Materials (2016 - 2020)

Trinity Biotech (TRIB) has disclosed Raw Materials for 5 consecutive years, with $12.2 million as the latest value for Q4 2020.

  • Quarterly Raw Materials fell 3.84% to $12.2 million in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $12.2 million through Dec 2020, down 3.84% year-over-year, with the annual reading at $12.2 million for FY2020, 3.84% down from the prior year.
  • Raw Materials hit $12.2 million in Q4 2020 for Trinity Biotech, down from $12.7 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $12.7 million in Q4 2019 to a low of $9.2 million in Q4 2016.
  • Historically, Raw Materials has averaged $11.0 million across 5 years, with a median of $10.6 million in 2018.
  • Biggest five-year swings in Raw Materials: grew 19.87% in 2019 and later decreased 3.84% in 2020.
  • Year by year, Raw Materials stood at $9.2 million in 2016, then increased by 12.74% to $10.3 million in 2017, then grew by 2.04% to $10.6 million in 2018, then rose by 19.87% to $12.7 million in 2019, then dropped by 3.84% to $12.2 million in 2020.
  • Business Quant data shows Raw Materials for TRIB at $12.2 million in Q4 2020, $12.7 million in Q4 2019, and $10.6 million in Q4 2018.